ACTEON Company Profile

September 26, 2019 | Advertorial

LISBON, Portugal: X-Mind prime is the latest addition to ACTEON’s CBCT digital imaging product line. It blends cutting-edge technology with ease of use in a compact design. With X-Mind prime 3D, high tech is at your fingertips with tools for accurate diagnosis and complete treatment planning. It is a lightweight and compact system that can fit into any dental office. ACTEON is showcasing its new product at the 28th Annual Scientific Meeting of the European Association for Osseointegration (EAO 2019), currently being held in Lisbon.

August 26, 2019 | Advertorial

Acteon präsentiert mit dem Pietzotome Cube Star die Weiterentwicklung seines Knochen-Ultraschallchirurgiegeräts auf der IDS. Mit dem neuen Pietzotome Cube Star gebe es weniger Schmerzen und weniger Blutungen, verspricht Laurent Zenou, Product Direktor Imaging bei Acteon. Implantologe Prof. Dr. Marcel Wainwright nennt das neue Gerät ein „Worldclass Tool“. Ebenfalls neu sind die 3-D Röntgengerät X-Mind prime und X-Mind trium.

March 29, 2019 | News

COLOGNE, Germany: At the 2019 International Dental Show (IDS), French company ACTEON released the latest addition to its 2 D and CBCT panoramic product line, the X-Mind prime. Mixing cutting-edge technology with enhanced simplicity, the new scanner generated a great deal of interest from attendees of IDS.

March 14, 2019 | News

COLOGNE, Germany: France-based company ACTEON earlier this week released its latest surgical device, Piezotome Cube STAR. Providing full preservation of crestal bone with a surgery duration comparable to that of rotary instruments and combining two patented technologies, NEWTRON and D.P.S.I., the new piezo-surgery device developed by ACTEON engineers’ clinical application team allows practitioners to drill safely into the bone and offers many other features.

March 13, 2019 | Advertorial

COLOGNE, Germany: Piezotome Cube STAR is a new piezo-surgery device manufactured by ACTEON. Being introduced at IDS 2019, Piezotome Cube STAR provides full preservation of the crestal bone with a surgery duration comparable to that of rotary instruments. Combining two patented technologies, Newtron and D.P.S.I., the new handpiece developed by ACTEON engineers allows practitioners to drill safely into the bone. Once again, ACTEON demonstrates its capacity for innovation and expertise in developing products that become the gold standard for dental surgery.

February 21, 2019 | Business

MT. LAUREL, N.J., U.S.: ACTEON North America is the only dental equipment manufacturer that offers comprehensive, minimally invasive solutions for the implant workflow, ranging from implant planning to surgery and maintenance.

February 14, 2019 | Education

Das kostenfreie Webinar bietet einen Überblick über die wichtigsten Einsatzmöglichkeiten piezoelektrischer Instrumente, von der schonenden Zahnextraktion über die sichere Entnahme von Knochenblöcken bis hin zur Sinusbodenelevation.

February 05, 2019 | News

ACTEON General Manager for the Middle East Amer Samaneh has been active in the dental industry for more than five years now. Samaneh has a degree in biomedical engineering and an MBA and previously worked in the medical business, a background he says has helped further his understanding of the dental market, promoting products and helping customers. In an interview at AEEDC Dubai, Dental Tribune International spoke to Samaneh about how ACTEON aims to provide the best care and services to the Middle East and why the event is so important to the company’s success.

December 13, 2018 | Business

ПАРИЖ, Франция: по заявлению компании ACTEON, ее ультразвуковой хирургический аппарат Piezotome CUBE выводит хирургию на принципиально новый уровень, делая имплантацию более безопасной и значительно более предсказуемой. На конгрессе ADF эксперты покажут, как применять новые стандарты костной хирургии в повседневной практике, используя революционные методы для сохранения исходной анатомии кости и сокращения продолжительности процедуры, что, безусловно, должно повысить приемлемость лечения для пациентов.